Shares of Advanced Cell Technology Inc. (OTC: ACTC), a biotechnology company engaged in the development and commercialization of human embryonic and adult stem cell technology in the emerging field of regenerative medicine, rose sharply in trading today.
ACTC shares ended the day 4.94% higher at $0.0595 on above average volume of 13.37 million. The stock hit an intra-day high of $0.06 in trading today.
ACTC shares gained today after the company announced that it allow the shareholder approval it had received to complete a reverse split of its common stock prior to year-end to lapse. The company cited market conditions and other corporate factors as the reasons for electing not complete reverse split.
Shares of Cellceutix Corp. (OTC: CTIX), an early-stage developmental biopharmaceutical company, gained in trading today.
CTIX shares ended the day 4.67% higher at $1.57 on above average volume of 940,762. The stock hit an all-time high of $1.58 in trading today. CTIX shares have gained 8.97% in the last three trading sessions.
CTIX last week announced that clinical trials being hosted at Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center for its flagship anti-cancer drug Kevetrin™ advanced to the next cohort.
Shares of CirTran Corp. (PINK: CIRC), a provider of a mix of high-and medium-volume manufacturing services and products using various applications for electronics OEMs in the communications, networking, peripherals, gaming, law enforcement, consumer products, telecommunications, automotive, medical and semiconductor industries, soared in trading today.
CIRC shares ended the day 30.43% higher at $0.0030 on above average volume of 106.51 million. The stock has gained 66.67% in the last three trading sessions.
Recent Comments